CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST

Jun Lu1, Shan Jiang2, Song Ye1

  • 1Department of Pathogen Biology and Immunology, School of Medicine, Anhui University of Science and Technology, P.R. China.

Biomedical Reports
|March 21, 2014
PubMed

Insights

This study explored Toll-like receptor 9 ligand (CpG) as an adjuvant for a Schistosoma japonicum vaccine. Combining CpG with the DNA vaccine enhanced immune responses and showed potential for improved schistosomiasis vaccine efficacy.

Area of Science:

  • Immunology
  • Parasitology
  • Vaccinology

Background:

  • Schistosomiasis is a major neglected tropical disease.
  • Toll-like receptor (TLR) ligands are explored as vaccine adjuvants.
  • Limited characterization of TLR ligands for schistosoma vaccines exists.

Purpose of the Study:

  • To evaluate a TLR9 ligand (CpG) as an adjuvant for a Schistosoma japonicum DNA vaccine (pVAX1-Sj26GST).
  • To investigate the adjuvant's effect on immune responses and regulatory T cell (Treg) function.

Main Methods:

  • Vaccination with pVAX1-Sj26GST DNA vaccine and CpG adjuvant.
  • In vitro assessment of Treg immunosuppressive function.
  • Measurement of cytokine production (IFN-γ, TNF-α, IL-4, IL-10, IL-2, IL-6) and immune cell expression (CD4+CD8+Foxp3+).

Main Results:

  • CpG adjuvant inhibited Treg immunosuppressive function.
  • Upregulation of key cytokines including IFN-γ, TNF-α, and IL-4.
  • Decreased CD4+CD8+Foxp3+ expression, suggesting reduced Treg activity.
  • Potential for enhanced antigen-specific T cell expansion.

Conclusions:

  • CpG acts as an effective adjuvant for the S. japonicum DNA vaccine.
  • The combination therapy may overcome Treg-mediated suppression.
  • Selective TLR ligand combinations show promise for increasing protective efficacy against schistosomiasis.

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K